Jory R. Baldridge

Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists

Axel G. Stöver, Jean da Silva Correia, Jay T. Evans et al. · Journal of Biological Chemistry · 2004 · 156 citations · Full text

Synthetic Toll-Like Receptor 4 Agonists Stimulate Innate Resistance to Infectious Challenge

Christopher W. Cluff, Jory R. Baldridge, Axel G. Stöver et al. · Infection and Immunity · 2005 · 109 citations · Full text

Inflammation, Toll-like Receptors, Compound Family +14

Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection

Jory R. Baldridge, Michael J. Buchmeier · Journal of Virology · 1992 · 84 citations · Full text

Vaccination, Humoral Protection, Mucosal Vaccination +15

Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets

Jory R. Baldridge, Ronald A. Barry, David J. Hinrichs · Infection and Immunity · 1990 · 75 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immunology +20

TLR4 agonists as immunomodulatory agents

Mark R. Alderson, Patrick O. McGowan, Jory R. Baldridge et al. · Journal of Endotoxin Research · 2006 · 72 citations

Microbial Pathogens, Innate Immune System, Immunology +17